Viney Lather
Viney Lather
Professor of Pharmaceutical Sciences
No verified email
Title
Cited by
Cited by
Year
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
K Madaan, S Kumar, N Poonia, V Lather, D Pandita
Journal of pharmacy & bioallied sciences 6 (3), 139, 2014
3902014
Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol
D Pandita, S Kumar, N Poonia, V Lather
Food Research International 62, 1165-1174, 2014
1752014
Cosmeceuticals: An emerging concept
VL Harish Dureja, Deepak Kaushik, Meenal Gupta, Vipin Kumar
Indian Journal of Pharmacology 37, 155-160, 2005
149*2005
Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases
A Singh Grewal, S Bhardwaj, D Pandita, V Lather, B Singh Sekhon
Mini Reviews in Medicinal Chemistry 16 (2), 120-162, 2016
1202016
Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel
D Pandita, A Ahuja, V Lather, B Benjamin, T Dutta, T Velpandian, RK Khar
Aaps Pharmscitech 12 (2), 712-722, 2011
902011
Hybrid poly (lactic-co-glycolic acid) nanoparticles: design and delivery prospectives
D Pandita, S Kumar, V Lather
Drug discovery today 20 (1), 95-104, 2015
862015
Nanostructured lipid carriers: versatile oral delivery vehicle
N Poonia, R Kharb, V Lather, D Pandita
Future science OA 2 (3), FSO135, 2016
732016
Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac
K Dua, K Pabreja, MV Ramana, V Lather
Journal of pharmacy and bioallied sciences 3 (3), 417, 2011
632011
Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique
D Pandita, A Ahuja, T Velpandian, V Lather, T Dutta, RK Khar
Die Pharmazie-An International Journal of Pharmaceutical Sciences 64 (5 …, 2009
632009
Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus
A Singh Grewal, B Singh Sekhon, V Lather
Mini Reviews in Medicinal Chemistry 14 (7), 585-602, 2014
552014
Topological models for the prediction of anti-HIV activity of dihydro (alkylthio)(naphthylmethyl) oxopyrimidines
V Lather, AK Madan
Bioorganic & medicinal chemistry 13 (5), 1599-1604, 2005
542005
Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid
K Madaan, V Lather, D Pandita
Drug delivery 23 (1), 254-262, 2016
422016
QSAR models for prediction of glycogen synthase kinase‐3β inhibitory activity of indirubin derivatives
V Lather, R Kristam, JS Saini, R Kristam, NA Karthikeyan, VN Balaji
QSAR & Combinatorial Science 27 (6), 718-728, 2008
342008
Stability indicating simplified HPLC method for simultaneous analysis of resveratrol and quercetin in nanoparticles and human plasma
S Kumar, V Lather, D Pandita
Food chemistry 197, 959-964, 2016
312016
Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators
N Charaya, D Pandita, AS Grewal, V Lather
Computational biology and chemistry 73, 221-229, 2018
292018
Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer
N Poonia, V Lather, D Pandita
Drug Discovery Today 23 (2), 315-332, 2018
292018
Green synthesis of therapeutic nanoparticles: an expanding horizon
S Kumar, V Lather, D Pandita
Nanomedicine 10 (15), 2451-2471, 2015
292015
Application of graph theory: Topological models for prediction of CDK-1 inhibitory activity of aloisines
V Lather, AK Madan
Croatica chemica acta 78 (1), 55-61, 2005
292005
Topological models for the prediction of HIV-protease inhibitory activity of tetrahydropyrimidin-2-ones
V Lather, AK Madan
Journal of Molecular Graphics and Modelling 23 (4), 339-345, 2005
282005
Toward the design of mutation‐resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis
V Kairys, MK Gilson, V Lather, CA Schiffer, MX Fernandes
Chemical biology & drug design 74 (3), 234-245, 2009
272009
The system can't perform the operation now. Try again later.
Articles 1–20